BioSpace News Archive

The American Institute of Biological Sciences (AIBS), Biodiversity Collections Network (BCoN), Natural Science Collections Alliance (NSC Alliance), and Society for the Preservation of Natural History Collections (SPNHC) surveyed individuals affiliated with US biodiversity science collections to better understand the effects of COVID-19 disruptions

BD announced that it has commenced registered offerings of $1.5 billion of common stock, par value $1.00 per share, and $1.5 billion of depositary shares, each representing a 1/20th interest in its mandatory convertible preferred stock, par value $1.00 per share, Series B.

AmerisourceBergen Corporation announced the closing of its public offering of $500 million aggregate principal amount of its 2.800% Senior Notes due May 15, 2030, in an underwritten registered public offering.

Transcat, Inc., a leading provider of accredited calibration, repair, inspection and laboratory instrument services and value-added distributor of professional grade handheld test, measurement and control instrumentation, reported financial results for its fourth quarter and fiscal year ended March 28, 2020.

The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is pleased to announced funding for 14 new projects in technology, workforce development, and in their Global Health Fund initiative, resulting from the Institute’s Project Call 3.1, and with a total value of approximately $10M.

Assembly Biosciences, Inc. (Nasdaq: ASMB) today announced that it will hold its 2020 Annual Meeting of Stockholders (Annual Meeting) solely by means of remote communication (i.e., a virtual-only stockholder meeting).

VolitionRx Limited, a multi-national epigenetics company that applies its Nucleosomics™ platform through its subsidiaries to develop simple, easy to use, cost-effective blood tests to help diagnose a range of cancers and other diseases, announced that it intends to offer and sell shares of its common stock in an underwritten public offering.

Bio-Techne Corporation (NASDAQ:TECH) and the Mount Sinai Health System in New York, through its commercial affiliate Kantaro Biosciences LLC (Kantaro), today announced a partnership to initiate scaled manufacturing and distribution of testing kits based on the Mount Sinai-developed COVID-19 serology test.

Galecto, Inc., a privately-held biotechnology company focused on the development of novel treatments for fibrosis and cancer, announced today that its Board of Directors has appointed Amit Munshi as its new Chairman.

Lipid peroxidation is one of the most commonly reported indices of oxidative stress and has been implicated as a contributing factor in a range of degenerative diseases, including diabetes, cardiovascular disease, Parkinson’s disease, Alzheimer’s disease and psychiatric disorders, including schizophrenia.